As previously discussed, there is likely to be a genetic element to epilepsy, which may involve opioid receptors, as mutations causing lower prodynorphin expression were demonstrated to correlate with increased susceptibility to epilepsy in people with a family history of TLE (59, 60). This evidence concerns the gene PDYN and epilepsy.